We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Biochip Array Technology Provides Simultaneous Multianalyte Testing

By HospiMedica staff writers
Posted on 04 Jun 2007
Biochip array technology allows multiple results from a single patient sample, minimizing biologic variation and resulting in a more rapid and accurate diagnosis.

The Biochip array technology was designed by Randox Laboratories (Crumlin, UK) and is based on enzyme-linked immunosorbant assay (ELISA) principles of competitive, sandwich, and antibody capture assays. More...
Biochip array technology utilizes a 9-mm2 biochip as a reaction platform, with multiple specific ligands (antibodies or antigens) attached at pre-defined sites on the surface. Up to 23 separate tests can be spotted as discrete test regions on the surface of the biochip, allowing 23 different results from as little as 7 ml of patient sample.

Biochip tests are grouped together as arrays and allow the detection of cytokines and growth factors, fertility and thyroid hormones, cell adhesion molecules, and drugs of abuse. Arrays are also available for the detection of biomarkers associated with cardiovascular disease and cancer. The Biochip platform is suitable for both proteomic and genomic analysis, providing test standardization for better performance and accuracy.

Randox is an international diagnostics company, headquartered in the United Kingdom. The company develops, manufactures, and markets clinical diagnostic products worldwide. The company's core products are: Biochip array technology; clinical chemistry analyzers and reagents; quality controls and external quality assessment (EQA); environmental diagnostics; recombinant proteins, and antibodies.


Related Links:
Randox Laboratories

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.